New Report Available: Iran Pharmaceuticals & Healthcare Report Q3 2014
BMI continues to adjust its forecasts for Iran's pharmaceutical market to account for the sanction-induced currency crisis and high rates of inflation. The rapid depreciation of the rial means that we expect the value of the market to contract sharply in US dollar terms. On a positive note, improved international relations have reduced the political risk associated with operating in the market for multinational drugmakers .
View full press release